Skip to main content
S 298 103th Congress Senate Commerce Biotechnology Foreign Trade and International Finance Imports Patents

A bill to amend title 35, United States Code, with respect to patents on certain processes.

Introduced: February 3, 1993 See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 13 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Aug 9, 1994
Referred to the Subcommittee on Intellectual Property and Judicial Administration.
Jul 19, 1993
Referred to the House Committee on Judiciary.
Jul 19, 1993
Received in the House.
Jul 16, 1993
Message on Senate action sent to the House.
Jul 15, 1993
Passed Senate without amendment by Voice Vote. (consideration: CR S8815)
Jul 15, 1993
Passed/agreed to in Senate: Passed Senate without amendment by Voice Vote.(consideration: CR S8815)
Jul 1, 1993
Placed on Senate Legislative Calendar under General Orders. Calendar No. 128.
Jul 1, 1993
Committee on Judiciary. Reported to Senate by Senator Biden without amendment. With written report No. 103-82.
May 6, 1993
Committee on Judiciary. Ordered to be reported without amendment favorably.
Mar 5, 1993
Referred to Subcommittee on Patents, Copyrights and Trademarks.
Feb 3, 1993
Read twice and referred to the Committee on Judiciary.
Feb 3, 1993
Sponsor introductory remarks on measure. (CR S1189-1191)
Feb 3, 1993
Introduced in Senate
 Plain-English summary Congressional Research Service

TABLE OF CONTENTS:

Title I: Biotechnological Process Patents

Title II: Biotechnological Material Patents

Title I: Biotechnological Process Patents - Amends Federal patent law to cite conditions under which a claimed process of making or using a machine, manufacture, or composition of matter is not obvious (thereby enhancing the patentability prospects of certain biotechnology processes). Establishes a presumption of validity with respect to a process claim even through a related product claim is invalidated (thus allowing a patentee to prove that the process claim is independently patentable from the product claim).

Title II: Biotechnological Material Patents - Makes any unauthorized person who imports or sells a product made by using a biotechnological material that is patented in the United States liable for patent infringement. Includes within the terms of such patents the right to exclude others from using, selling, or importing such products throughout or into the United States. Establishes exceptions to such requirements to the extent suitable to protect commercial investment made or business commenced before the effective date of such amendments.

What's happening now August 9, 1994

Referred to the Subcommittee on Intellectual Property and Judicial Administration.

 Committees of jurisdiction 4
 Cosponsors 1
All 1 Republican 1